Skip to main content
. 2018 Jul 3;8:10010. doi: 10.1038/s41598-018-28263-7

Table 1.

Investigation of miscellaneous amide analogues.

graphic file with name 41598_2018_28263_Figa_HTML.gif
R hSUCNR1 mSUCNR1 ClogPb
pEC50 (efficacy, %)a
3 graphic file with name 41598_2018_28263_Figb_HTML.gif 5.75 ± 0.08 (72.8 ± 2.6) 6.46 ± 0.06 (79.3 ± 1.6) 1.66
4 graphic file with name 41598_2018_28263_Figc_HTML.gif 4.53 ± 0.13 (78.1 ± 7.5) 4.93 ± 0.05 (95.8 ± 2.9) 0.44
5 graphic file with name 41598_2018_28263_Figd_HTML.gif 22% @10−4M 13% @10−4M 0.28
6 graphic file with name 41598_2018_28263_Fige_HTML.gif 50% @10−4M 64% @10−4M 1.52
7 graphic file with name 41598_2018_28263_Figf_HTML.gif 8% @10−4M 15% @10−4M 1.26
8 graphic file with name 41598_2018_28263_Figg_HTML.gif 5% @10−4M 11% @10−4M 1.28
9 graphic file with name 41598_2018_28263_Figh_HTML.gif 25% @10−4M 15% @10−4M 2.44

apEC50 values were determined from dose-response curves of induction of IP3 turnover in SUCNR1 transfected HEK cells (N = 3), efficacy is determined relative to succinate (100%). bCalculated by BioByte’s algorithm as implemented in ChemDraw Professional 16.0.1.4 (ClogP option).